Skip to content
Search

Latest Stories

Calls for prescription charges to be scrapped altogether during Covid-19 crisis

Professional bodies representing doctors and pharmacists have asked the government to scrap prescription charges in England during the coronavirus crisis.

In a joint letter to Health Secretary Matt Hancock, Pharmaceutical Services Negotiating Committee, British Medical Association and Dispensing Doctors’ Association have argued that an increased level of risk would always remain for both dispensers and patients as long as patients were required to sign and pay for their prescriptions.


The three bodies recommend “the introduction of temporary removal of the prescription charge altogether” so as “to allow for a smoother and safer prescription for all.”

The letter further states: "We understand that the Government intends to extend the validity period for exemption certificates for low income, maternity and medical exemptions to ensure that already vulnerable patients in these categories will not need a renewed exemption certificate and can use their existing certificate.”

The bodies agree that this would reduce the chances of infection and workload.

They have also asked for “a temporary suspension of the need for a signature when collecting controlled drugs from a dispenser” and hope “unnecessary bureaucracy” such as signing a declaration on the prescription form or EPS token is reduced.

“This is an unnecessary process generating both additional work and cost for both patient and dispenser and we recommend removing the process permanently.”

The charges only apply to patients in England as prescriptions are free in the other three nations of the UK.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less